BiPAP AVAPS 00 (REF 1167P)Recalls & reported problems
Respironics, Inc. · BiPAP AVAPS C-Series, China, FGD SA · Class 2
- Adverse event reports
- 10
- Deaths reported
- 2
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 10 adverse event reports that list this exact device (DI 00606959039261), received between Aug 30, 2021 and Dec 9, 2025 — classified as 2 deaths, 1 injury, 7 malfunctions.
The most frequently reported specific device problem is “Degraded” (5 reports).
1 other recall cover devices cleared under the same FDA submission (K102465); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Degraded5
- Electrical /Electronic Property Problem3
- Adverse Event Without Identified Device or Use Problem1
- Mechanical Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions7
- Cancer1
- Insufficient Information1
- Pulmonary Emphysema1
Recent adverse event reports
The 10 most recent of 10 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 9, 2025Electrical /Electronic Property Problem; Electrical /Electronic Property Problem
THE MANUFACTURER RECEIVED INFORMATION FROM A HOSPITAL ALLEGING A VENTILATOR ALARM OCCURRED AND DEVICE STILL DID NOT OPERATE AFTER ADJUSTMENT. THERE WAS NO PATIENT HARM OR INJURY REPORTED WITH THIS NOTIFICATION. THE DEVICE HAS NOT YET BEEN RETURNED TO THE MANUFACTURER FOR EVALUATION. GOOD FAITH EFFORTS ARE ACTIVELY BEING MADE TO HAVE THE DEVICE RETURNED FOR EVALUATION. IF THE DEVICE IS RETURNED FOR EVALUATED, A FOLLOW-UP REPORT WILL BE SUBMITTED WITH THE EVALUATION RESULTS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23760782 ↗MalfunctionOct 2, 2024Degraded; Degraded
THIS COMPLAINT HAS BEEN REVIEWED FOR THE INFORMATION THE MANUFACTURER RECEIVED "THE UNIT STOPPED AFTER UNO" AND WILL BE REPORTED AS A PRODUCT PROBLEM. ALTHOUGH THERE WAS NO PATIENT HARM OR INJURY, AS THE EVENTS DO NOT MEET THE DEFINITION OF A REPORTABLE SERIOUS INJURY COMPLAINT PER THE FDA REGULATIONS (21 CFR 803) THIS EVENT IS REPORTABLE BECAUSE THE FAILURE COULD AFFECT THE ABILITY OF THE DEVICE TO PROVIDE THERAPY TO PUBLISHED SPECIFICATIONS. A REPORT WILL BE FILED WITH ALL APPLICABLE REGULATORY AGENCIES.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20349748 ↗MalfunctionMar 22, 2024Electrical /Electronic Property Problem; Electrical /Electronic Property Problem
THE MANUFACTURER RECEIVED INFORMATION ALLEGING A VENTILATOR CRITICAL ERROR OCCURRED. THERE WAS NO HARM OR INJURY REPORTED. NO MEDICAL INTERVENTIONS WERE SPECIFIED. DURING THE EVALUATION OF THE DEVICE AT THE MANUFACTURER'S SERVICE CENTER, THE DEVICE LOG CONFIRMED THE ALLEGATION. THE DEVICE'S MAIN PCA WAS REPLACED TO REPAIR THE DEVICE. THE DEVICE PASSED ALL TESTS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18960242 ↗MalfunctionFeb 22, 2024Mechanical Problem; Mechanical Problem
THE MANUFACTURER RECEIVED INFORMATION ALLEGING A VENTILATOR WAS STOPPED WORKING. THERE WAS NO HARM OR INJURY REPORTED. THE DEVICE HAS NOT BEEN RETURNED TO THE MANUFACTURER. AT THIS TIME, WE ARE UNABLE TO CONFIRM THE ALLEGED MALFUNCTION. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE MANUFACTURER'S INVESTIGATION IS COMPLETE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18758943 ↗MalfunctionDec 13, 2023Electrical /Electronic Property Problem; Electrical /Electronic Property Problem
THE MANUFACTURER RECEIVED INFORMATION ALLEGING A VENTILATOR POWER CORD WAS SMOKING AND BURNT. THERE WAS NO HARM OR INJURY REPORTED. THE MANUFACTURER'S INVESTIGATION IS ONGOING. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE MANUFACTURER'S INVESTIGATION IS COMPLETE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18322888 ↗InjuryNov 15, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE MANUFACTURER RECEIVED INFORMATION ALLEGING THAT A 67-YEAR-OLD PATIENT SUFFERING FROM CHRONIC OBSTRUCTIVE PULMONARY DISEASE RECEIVED A DIAGNOSIS OF A LUNG MASS FOLLOWING THE USE OF A VENTILATOR. IT WAS REPORTED THAT THE MASS IN THE LUNGS FOR THE PATIENT WAS NINETY PERCENT (90%) LUNG CANCER AND REACHED A SIZE OF THREE TO FIVE CENTIMETERS (3-5 CM). NO ADDITIONAL CLINICAL INFORMATION OR MEDICAL INTERVENTION HAS BEEN SPECIFIED AT THIS TIME. THE MANUFACTURER'S INVESTIGATION IS ONGOING. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE MANUFACTURER'S INVESTIGATION IS COMPLETE.
Patient problems: Cancer
MAUDE report 18140283 ↗MalfunctionMar 15, 2022Degraded; Degraded
THE MANUFACTURER RECEIVED INFORMATION ALLEGING AN ISSUE RELATED TO A BIPAP DEVICE'S SOUND ABATEMENT FOAM. THE DEVICE WAS RETURNED AND OBSERVE REPLACED MAIN PCA AND HUMID BASE CABLE DURING DEVICE EVALUATION THERE WAS NO ALLEGATION OF HARM OR INJURY. THIS ISSUE WAS REPORTED TO THE FDA PER 21 CFR 806. THE DEVICE WILL BE CORRECTED PER RES 88058.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13771965 ↗MalfunctionOct 28, 2021Degraded; Degraded
THE MANUFACTURER RECEIVED INFORMATION ALLEGING AN ISSUE RELATED TO A BIPAP POSITIVE AIRWAY PRESSURE (BIPAP) DEVICE'S SOUND ABATEMENT FOAM. THERE WAS NO REPORT OF PATIENT HARM OR INJURY. THIS ISSUE WAS REPORTED TO THE FDA PER 21 CFR 806. THE DEVICE WILL BE CORRECTED PER RES 88058.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12713086 ↗DeathSep 16, 2021Degraded; Degraded
THE MANUFACTURER RECEIVED INFORMATION ALLEGING A CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICE'S SOUND ABATEMENT FOAM BECAME DEGRADED AND CAUSED THE PATIENT TO DEVELOP FUNGAL INFECTION. THE PATIENT HAS REPORTEDLY HOSPITALIZED IN RESPONSE TO THE EVENT AND HAS SINCE DIED. THIS ISSUE WAS REPORTED TO THE FDA PER 21 CFR 806. THE DEVICE WILL BE CORRECTED PER RES 88058.
Patient problems: Pulmonary Emphysema
MAUDE report 12485060 ↗DeathAug 30, 2021Degraded; Degraded
THE MANUFACTURER RECEIVED INFORMATION ALLEGING A BIPAP DEVICE'S SOUND ABATEMENT FOAM BECAME DEGRADED. THE PATIENT EXPIRED IN (B)(6) 2021. THIS ISSUE WAS REPORTED TO THE FDA PER 21 CFR 806. THE DEVICE WILL BE CORRECTED PER RES 88058.
Patient problems: Insufficient Information
MAUDE report 12388129 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K102465. One submission often covers many models, so check the product and lot details in each record.
- Z-1973-2021 · Jun 14, 2021 · Open, ClassifiedDreamStation ASV, DreamStation ST, AVAPS, SystemOne ASV4, C-Series ASV, C-Series S/T and AVAPS, OmniLab Advanced+ Continuous Ventilator, Non-life Supporting The Philips Respiron
Other VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING devices
- DreamStation BiPAP ST30 00Respironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING5 deaths547 reports
- DreamStation BiPAP ST30 00Respironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING3 deaths283 reports
- BiPAP AVAPS BiPAP AVAPS C Series, 30cm, INTLRespironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING274 reports
- BiPAP autoSV Advanced System One 60 Series BiPAP autoSV Advanced w/H Tube Humid, 60 Series, USRespironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING3 deaths209 reports
- BiPAP S/T C-Series BiPAP S/T C Series Core Pack, 30cm, USRespironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING1 death200 reports
- DreamStation BiPAP AVAPS DreamStation BiPAP AVAPS30 w/Humidifier w/Cell, USRespironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING4 deaths174 reports
- DreamStation BiPAP AVAPS DreamStation AVAPS30 w/Humid w/H Tube w/Cell, USRespironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING2 deaths144 reports
- BiPAP A30 00Respironics, Inc. · VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING2 recalls29 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.